title: Between-Country Inequalities in the Neglected Tropical Disease Burden in 1990 and 2010, with Projections for 2020.
abstract: The World Health Organization (WHO) has set ambitious time-bound targets for the control and elimination of neglected tropical diseases (NTDs). Investing in NTDs is not only seen as good value for money, but is also advocated as a pro-poor policy since it would improve population health in the poorest populations. We studied the extent to which the disease burden from nine NTDs (lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminths, trachoma, Chagas disease, human African trypanosomiasis, leprosy, visceral leishmaniasis) was concentrated in the poorest countries in 1990 and 2010, and how this would change by 2020 in case the WHO targets are met.
  
  
  
  Our analysis was based on 1990 and 2010 data from the Global Burden of Disease (GBD) 2010 study and on projections of the 2020 burden. Low and lower-middle income countries together accounted for 69% and 81% of the global burden in 1990 and 2010 respectively. Only the soil-transmitted helminths and Chagas disease caused a considerable burden in upper-middle income countries. The global burden from these NTDs declined by 27% between 1990 and 2010, but reduction largely came to the benefit of upper-middle income countries. Achieving the WHO targets would lead to a further 55% reduction in the global burden between 2010 and 2020 in each country income group, and 81% of the global reduction would occur in low and lower-middle income countries.
  
  
  
  The GBD 2010 data show the burden of the nine selected NTDs in DALYs is strongly concentrated in low and lower-middle income countries, which implies that the beneficial impact of NTD control eventually also largely comes to the benefit of these same countries. While the nine NTDs became increasingly concentrated in developing countries in the 1990-2010 period, this trend would be rectified if the WHO targets were met, supporting the pro-poor designation.
authors.affiliation: Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
authors.forename: Wilma A
authors.initials: WA
authors.lastname: Stolk
authors.affiliation: Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.|Center for Tobacco Control Research and Education, University of California, San Francisco, San Francisco, California, United States of America.
authors.forename: Margarete C
authors.initials: MC
authors.lastname: Kulik
authors.affiliation: Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
authors.forename: Epke A
authors.initials: EA
authors.lastname: le Rutte
authors.affiliation: Bill & Melinda Gates Foundation, Seattle, Washington, United States of America.
authors.forename: Julie
authors.initials: J
authors.lastname: Jacobson
authors.affiliation: Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
authors.forename: Jan Hendrik
authors.initials: JH
authors.lastname: Richardus
authors.affiliation: Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
authors.forename: Sake J
authors.initials: SJ
authors.lastname: de Vlas
authors.affiliation: Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
authors.forename: Tanja A J
authors.initials: TA
authors.lastname: Houweling
mesh_terms: D017281:Cost of Illness; D006801:Humans; D007182:Income; D058069:Neglected Diseases / Q000191:economics / Q000453:epidemiology*; D013997:Time Factors; D014330:Tropical Medicine